Your session is about to expire
← Back to Search
Dynamic FAZA PET and Multiparametric MR Imaging for Brain Tumor
Phase < 1
Waitlist Available
Led By Caroline Chung
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Cervical Cohort: Adult females (>18 years old) with newly diagnosed cervical cancer who are able to provide informed consent, receiving surgery, radiotherapy, or chemotherapy, and have no contraindications to MRI with gadolinium contrast or 18F-FAZA PET
Glioma Cohort: Adult patients (> 18 years old) with newly diagnosed or recurrent high grade glioma with newly confirmed pathology (within 1 month) who are able to provide informed consent and have no contraindications to MRI with gadolinium contrast or 18F-FAZA PET
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial is investigating if brain tumors with greater hypoxia, as defined by qBOLD and 18F-FAZA PET, have certain pathological features including proportionate necrosis, Ki-67 and IDH mutation status.
Who is the study for?
This trial is for adults over 18 with high grade glioma (brain tumor) or newly diagnosed cervical cancer. Participants must be receiving surgery, radiotherapy, or chemotherapy and have no issues with MRI or PET scans using specific contrasts. They should be able to give informed consent.
What is being tested?
The study is testing the use of dynamic FAZA PET scans and multiparametric MR imaging to evaluate oxygen levels, metabolism, and blood supply in brain tumors and cervical cancers. It aims to understand how these factors relate to each other.
What are the potential side effects?
Since this trial involves diagnostic procedures rather than treatments, side effects are minimal but may include discomfort from lying still during imaging and potential reactions to contrast agents used in MRI or PET scans.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am an adult woman with new cervical cancer, getting treatment, and can have MRI or PET scans.
Select...
I am an adult with a new or returning high-grade brain tumor and can undergo MRI and PET scans.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: 18F-FTXExperimental Treatment1 Intervention
The radioactive tracer (FAZA)
Find a Location
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
3,070 Previous Clinical Trials
1,802,788 Total Patients Enrolled
Caroline ChungPrincipal InvestigatorM.D. Anderson Cancer Center
4 Previous Clinical Trials
213 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am an adult woman with new cervical cancer, getting treatment, and can have MRI or PET scans.I am an adult with a new or returning high-grade brain tumor and can undergo MRI and PET scans.I do not have conditions that prevent PET-MRI scans or weigh over 400 pounds.
Research Study Groups:
This trial has the following groups:- Group 1: 18F-FTX
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.